Global Dialysis Market Report: 2013 Edition
ESRD
(End Stage Renal Disease) refers to permanent kidney failure. It is the final
stage of Chronic Kidney Disease (CKD) where the kidney functions at less than
10-15% of the normal capacity. The growing prevalence of diabetes, hypertension
and large elderly population are rapidly driving the number of ESRD patients
globally. There are two methods used for treating ESRD patients: kidney
transplant or dialysis.
To Read The Complete Report with
TOC:-
Dialysis
is the process of blood purification i.e. the removal of waste and toxic
substances from the body and it can be done via two procedures viz. peritoneal
dialysis (PD) or hemodialysis (HD). The major dialysis products include
dialyzers, hemodialysis machines, dialysis concentrates and peritoneal dialysis
products. Diabetes and high blood pressure are among the key causative factors
for kidney failure leading to an increase in the number of patients suffering
from CKD and ESRD.
This
report analyzes the global dialysis market with focus on its segments
including: dialysis services, dialysis products, and dialysis drugs. Moreover,
the regional market of China is also discussed. Furthermore market dynamics
such as the industry trends and development, key growth drivers and challenges
faced by the industry are also elicited in detail.
To Buy a Copy Of This Report:-
On
the contention front, the global dialysis market is fiercely competitive with a
handful of player reining the whole market. The key industry players are
Baxter, Fresenius, DaVita and Gambro. The competitive landscape of the industry
along with the key industry players’ profiles are also added herein.
Contact:-
M/s
Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment